Drug Profile
Cancer vaccine - Immune Response
Alternative Names: GM-CSF cancer vaccine - Immune Response; mbGM-CSF cancer vaccine - Immune ResponseLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Immune Response Corporation
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer; Malignant melanoma
Most Recent Events
- 31 Dec 2003 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
- 31 Dec 2003 Discontinued - Preclinical for Malignant melanoma in USA (unspecified route)
- 04 Apr 2003 No development reported - Preclinical for Colorectal cancer in USA (unspecified route)